Literature DB >> 12088077

Hydrogen proton magnetic resonance spectroscopy in autism: preliminary evidence of elevated choline/creatine ratio.

Deborah K Sokol1, David W Dunn, Mary Edwards-Brown, Judy Feinberg.   

Abstract

Hydrogen proton magnetic resonance spectroscopy is only beginning to be studied in autistic individuals. We report an association between hydrogen proton magnetic resonance spectroscopy choline/creatine ratios and severity of autism as measured by the Children's Autistic Rating Scale (Pearson r = .657, P = .04) in 10 autistic children. Hydrogen proton magnetic resonance spectroscopy choline/creatine ratio measures the concentration of cytosolic choline including free choline used in the synthesis of acetylcholine. Elevation in this ratio has been interpreted as a result of membrane degradation such as caused by a tumor or, alternatively, as a result of choline synthesis associated with increased cellular proliferation. Recent neuropathologic evidence has implicated disruption of acetylcholine transmission in the brains of autistic adults. A case-controlled study of hydrogen proton magnetic resonance spectroscopy choline/creatine ratios is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088077     DOI: 10.1177/088307380201700401

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

Review 2.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

3.  Relation of behavior problems with findings of cranial diffusion tensor MRI and MR spectroscopy in autistic children.

Authors:  Torel Ogur; Oznur Leman Boyunaga
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism.

Authors:  M Zeegers; J van der Grond; E van Daalen; J Buitelaar; H van Engeland
Journal:  J Neural Transm (Vienna)       Date:  2006-05-24       Impact factor: 3.575

5.  Magnetic resonance spectroscopy features of the thalamus and the cerebellum and their association with clinical features in children with autism spectrum disorder: a prospective study.

Authors:  Qian-Qian Kang; Xu Li; Guang-Lei Tong; Ya-Lan Fan; Lei Shi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-12-15

6.  Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism.

Authors:  Golan Karvat; Tali Kimchi
Journal:  Neuropsychopharmacology       Date:  2013-10-07       Impact factor: 7.853

7.  [Proton magnetic resonance spectroscopy in Asperger's syndrome: correlations with neuropsychological test scores].

Authors:  Ozgür Oner; Halise Devrimci Ozgüven; Ferhunde Oktem; Banu Yağmurlu; Bora Baskak; Senay Olmez; Kerim Munir
Journal:  Turk Psikiyatri Derg       Date:  2009

8.  Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.

Authors:  O Oner; H Devrimci-Ozguven; F Oktem; B Yagmurlu; B Baskak; K M Munir
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

9.  Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.

Authors:  Anthony Bejjani; Joseph O'Neill; John A Kim; Andrew J Frew; Victor W Yee; Ronald Ly; Christina Kitchen; Noriko Salamon; James T McCracken; Arthur W Toga; Jeffry R Alger; Jennifer G Levitt
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 10.  Potential therapeutic use of the ketogenic diet in autism spectrum disorders.

Authors:  Eleonora Napoli; Nadia Dueñas; Cecilia Giulivi
Journal:  Front Pediatr       Date:  2014-06-30       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.